What is AceAge?
AceAge operates at the intersection of healthcare technology and patient autonomy, focusing on the development of intuitive products designed to improve health outcomes for elderly individuals. Its core offering, Karie, serves as a sophisticated personal health companion that automates the scheduling and dispensing of medication. By mitigating the risks associated with poor medication adherence, AceAge provides a vital service for patients living independently. The company's market position is bolstered by strategic collaborations and a clear mission to enhance the aging process through technological innovation, effectively bridging the gap between clinical requirements and daily patient management.
How much funding has AceAge raised?
AceAge has raised a total of $7.6M across 3 funding rounds:
Angel/Seed
$2M
Series A
$5M
Other Financing Round
$616K
Angel/Seed (2017): $2M, investors not publicly disclosed
Series A (2020): $5M led by Longliv Ventures
Other Financing Round (2022): $616K supported by Ontario Together Fund
Key Investors in AceAge
Longliv Ventures
Longliv Ventures is a strategic investor and partner that aims to empower consumers worldwide by addressing significant health and lifestyle challenges through innovative solutions. As part of the CK Hutchison Holdings Group, they leverage extensive resources in healthcare technology to drive success in the digital health space.
Ontario Together Fund
A government-backed investment initiative focused on supporting organizations that provide innovative solutions to address critical health and economic challenges.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for AceAge?
With the recent influx of capital, AceAge is poised to accelerate its product development roadmap and deepen its market penetration. The strategic focus will likely shift toward scaling distribution channels and enhancing the interoperability of the Karie platform with broader healthcare ecosystems. As the company transitions into a more mature enterprise phase, the emphasis will remain on maintaining high standards of patient safety while exploring new opportunities in chronic condition management. The backing from key strategic partners provides the necessary resources to navigate the complexities of global health markets and solidify AceAge's status as a leader in the digital health space.
See full AceAge company page
